Q2 2026 13F filing
Updated 27 days ago68 disclosed positions worth $2.3B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E EQR ERASCA INC | $222.6M | 12.15M | 9.58% | — |
| 2 | A AAVXF ABIVAX SA | $136.5M | 1.02M | 5.87% | — |
| 3 | R RVMDW REVOLUTION MEDICINES INC | $131.1M | 700.0K | 5.64% | — |
| 4 | I IDYA IDEAYA BIOSCIENCES INC | $111.8M | 3.00M | 4.81% | — |
| 5 | B BNTX BIONTECH SE | $94.4M | 1.01M | 4.07% | — |
| 6 | V VERA VERA THERAPEUTICS INC | $94.4M | 2.20M | 4.06% | — |
| 7 | T TNGX TANGO THERAPEUTICS INC | $89.1M | 2.85M | 3.84% | — |
| 8 | P PRAX PRAXIS PRECISION MEDICINES I | $87M | 260.0K | 3.75% | — |
| 9 | C CLDX CELLDEX THERAPEUTICS INC NEW | $78.1M | 2.10M | 3.36% | — |
| 10 | D DNTH DIANTHUS THERAPEUTICS INC | $78M | 800.0K | 3.36% | — |
| 11 | C CGON CG ONCOLOGY INC | $71M | 1.00M | 3.06% | — |
| 12 | I IRON DISC MEDICINE INC | $64M | 875.0K | 2.75% | — |
| 13 | M MAZE MAZE THERAPEUTICS INC | $57.7M | 1.94M | 2.49% | — |
| 14 | D DYN DYNE THERAPEUTICS INC | $56.6M | 2.55M | 2.44% | — |
| 15 | M MLTX MOONLAKE IMMUNOTHERAPEUTICS | $52.1M | 2.67M | 2.24% | — |
| 16 | O OCFC OCULAR THERAPEUTIX INC | $52M | 5.30M | 2.24% | — |
| 17 | D DSGN DESIGN THERAPEUTICS INC | $43.4M | 3.00M | 1.87% | — |
| 18 | O OLMA OLEMA PHARMACEUTICALS INC | $40.1M | 3.21M | 1.73% | — |
| 19 | B BLTE BELITE BIO INC | $38.5M | 250.0K | 1.66% | — |
| 20 | A ACHV ACHIEVE LIFE SCIENCE INC | $35.4M | 5.42M | 1.52% | — |
| 21 | T TRVI TREVI THERAPEUTICS INC | $35.1M | 1.88M | 1.51% | — |
| 22 | C COGT COGENT BIOSCIENCES INC | $34.8M | 900.0K | 1.50% | — |
| 23 | ? N/A ARRIVENT BIOPHARMA INC | $34.7M | 1.00M | 1.50% | — |
| 24 | ? N/A CRESCENT BIOPHARMA INC. | $34.2M | 1.90M | 1.47% | — |
| 25 | C CMPS COMPASS PATHWAYS PLC | $31.8M | 2.25M | 1.37% | — |
| 26 | M MLYS MINERALYS THERAPEUTICS INC | $28.3M | 1.05M | 1.22% | — |
| 27 | Q QCOM REPLIMUNE GROUP INC | $27.7M | 2.50M | 1.19% | — |
| 28 | X XENE XENON PHARMACEUTICALS INC | $27.2M | 450.0K | 1.17% | — |
| 29 | G GPCR STRUCTURE THERAPEUTICS INC | $26.8M | 500.0K | 1.16% | — |
| 30 | I IMVT IMMUNOVANT INC | $25.6M | 665.0K | 1.10% | — |
| 31 | J JBIO JADE BIOSCIENCES INC | $25M | 1.13M | 1.08% | — |
| 32 | E ELVN ENLIVEN THERAPEUTICS INC | $23.6M | 465.0K | 1.02% | — |
| 33 | M MANE VERADERMICS INC | $22.1M | 180.0K | 0.95% | — |
| 34 | A AVTX AVALO THERAPEUTICS INC | $21.3M | 1.15M | 0.91% | — |
| 35 | R RCUS ARCUS BIOSCIENCES INC | $20M | 650.0K | 0.86% | — |
| 36 | S SMMT SUMMIT THERAPEUTICS INC | $19.7M | 1.35M | 0.85% | — |
| 37 | I IMCR IMMUNOCORE HLDGS PLC | $19.1M | 600.0K | 0.82% | — |
| 38 | L LBRX LB PHARMACEUTICALS INC | $19M | 585.0K | 0.82% | — |
| 39 | N NERV MINERVA NEUROSCIENCES INC | $18.3M | 3.29M | 0.79% | — |
| 40 | F FTH FAETH THERAPEUTICS INC | $18.1M | 722.0K | 0.78% | — |
| 41 | C CRSP CRISPR THERAPEUTICS AG | $16.4M | 300.0K | 0.70% | — |
| 42 | D DBVTF DBV TECHNOLOGIES S A | $15M | 915.0K | 0.65% | — |
| 43 | P PBLS PARABILIS MEDICINES INC | $14.4M | 525.0K | 0.62% | — |
| 44 | R RYTM RHYTHM PHARMACEUTICALS INC | $13.9M | 125.0K | 0.60% | — |
| 45 | V VOR VOR BIOPHARMA INC | $12M | 650.0K | 0.52% | — |
| 46 | S SRRK SCHOLAR ROCK HLDG CORP | $11M | 200.0K | 0.47% | — |
| 47 | ? N/A IMMIX BIOPHARMA INC | $10.3M | 1.00M | 0.44% | — |
| 48 | Q QTTB Q32 BIO INC | $10.2M | 800.0K | 0.44% | — |
| 49 | O ODTX ODYSSEY THERAPEUTICS INC | $9.8M | 521.7K | 0.42% | — |
| 50 | A ANNX ANNEXON INC | $8.6M | 1.50M | 0.37% | — |